Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study

BACKGROUND: Long-acting beta-agonists were one of the first-choice bronchodilator agents for stable chronic obstructive pulmonary disease. But the impact of long-acting beta-agonists on mortality was not well investigated. METHODS: National Emphysema Treatment Trial provided the data. Severe and ver...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Horita, Nobuyuki, Miyazawa, Naoki, Morita, Satoshi, Kojima, Ryota, Kimura, Naoko, Kaneko, Takeshi, Ishigatsubo, Yoshiaki
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674977/
https://ncbi.nlm.nih.gov/pubmed/23725215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-14-62
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars